Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytochrome P450 1A2/2C18/2C19 (Homo sapiens (Human)) | BDBM461264 (US10774056, Compound 028 | US11542242, Compound 02...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 1A2/2C18/2C19 (Homo sapiens (Human)) | BDBM461268 (US10774056, Compound 032 | US11542242, Compound 03...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 1A2/2C18/2C19 (Homo sapiens (Human)) | BDBM461258 (US10774056, Compound 007 | US11542242, Compound 00...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 1A2/2C18/2C19 (Homo sapiens (Human)) | BDBM461260 (US10774056, Compound 022 | US11542242, Compound 02...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 1A2/2C18/2C19 (Homo sapiens (Human)) | BDBM461263 (US10774056, Compound 027 | US11542242, Compound 02...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 1A2/2C18/2C19 (Homo sapiens (Human)) | BDBM461266 (US10774056, Compound 030 | US11542242, Compound 03...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 1A2/2C18/2C19 (Homo sapiens (Human)) | BDBM461267 (US10774056, Compound 031 | US11542242, Compound 03...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 1A2/2C18/2C19 (Homo sapiens (Human)) | BDBM461257 (US10774056, Compound 006 | US11542242, Compound 00...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 1A2/2C18/2C19 (Homo sapiens (Human)) | BDBM461256 (US10774056, Compound 003 | US11542242, Compound 00...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 1A2/2C18/2C19 (Homo sapiens (Human)) | BDBM461261 (US10774056, Compound 025 | US11542242, Compound 02...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair |